US Patent Issued to JBKLAB on April 21 for "Pharmaceutical composition for preventing, alleviating, or treating cancer containing 2,6-dichloro-4-(4-(4-hydroxycyclohexylamino)-7H- pyrrolo[2,3-dpyrimidin-5-yl)phenol as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,382, issued on April 21, was assigned to JBKLAB Co. Ltd. (Seongnam-si, South Korea).

"Pharmaceutical composition for preventing, alleviating, or treating cancer containing 2,6-dichloro-4-(4-(4-hydroxycyclohexylamino)-7H- pyrrolo[2,3-dpyrimidin-5-yl)phenol as active ingredient" was invented by Bong Keun Jang (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for preventing or treating cancer, containing 2,6-dichloro-4-(4-(4-hydroxycyclohexylamino)-7H-pyrrolo[2,3-D]pyrimidin-5-yl)phenol as an active ingredient. It has been ascertained that the present invention inhibi...